Unable to display image

 

Daily Headlines
DAILY HEADLINES FROM MEDPAGE TODAY PUTTING BREAKING MEDICAL NEWS INTO PRACTICE
Daily Headlines
Wednesday April 02, 2008

Medpagetoday.com

TODAY'S HEADLINES
Add us to your address book or trusted sender list to help ensure delivery.


For the latest news, features, columns, video and audio reports and more, visit our home page at www.medpagetoday.com

ACC: Confirmation that Rosuvastatin (Crestor) Regresses Coronary Stenoses CME (with video)
CHICAGO -- Reversal of coronary stenosis seen by intravascular ultrasound after two years of rosuvastatin (Crestor) treatment has been confirmed in the same patients by quantitative coronary angiography, researchers reported here. full story
http://www.medpagetoday.com/MeetingCoverage/ACCMeeting/tb/8980
 
 
Anemia Drugs’ Marketing in Congressional Crosshairs 
WASHINGTON -- A House committee announced today it has launched an inquiry into the marketing practices of the makers of epoetin alfa (Epogen, Procrit) and darbopoetin alfa (Aranesp), particularly direct-to-consumer promotion. full story
http://www.medpagetoday.com/ProductAlert/Prescriptions/tb/8991

Summer Births Linked to Later Myopia CME
JERUSALEM -- The season of birth apparently affects the chances of developing myopia in young adulthood, according to researchers here. full story
http://www.medpagetoday.com/Ophthalmology/GeneralOphthalmology/tb/8989

ACC: Resynchronization Therapy Found Beneficial in Milder Heart Failure  CME
CHICAGO -- In class I or II heart failure, cardiac resynchronization therapy plus optimal drug treatment induced reverse left ventricular remodeling, Swedish researchers said here. full story
http://www.medpagetoday.com/MeetingCoverage/ACCMeeting/tb/8988

Surgery or Stenting Controversy Gets Last Words at ACC 
CHICAGO -- This exclusive MedPage Today broadcast -- the final press conference from the American College of Cardiology meeting -- features reports on six studies, including a head-to-head trial comparing CABG with stenting. full story
http://www.medpagetoday.com/MeetingCoverage/ACCMeeting/tb/8875

Devices, Diets, and Diagnostics: The Prevention Toolbox 
CHICAGO -- In this exclusive MedPage Today broadcast of a late-breaking clinical trials session at the American College of Cardiology meeting, researchers report data from IVUS evaluation of a diet drug from inside the artery as well as findings on the efficacy of home defibrillators and daily data collection from an ICD. full story
http://www.medpagetoday.com/MeetingCoverage/ACCMeeting/tb/8874

Rapid TB Assay Aces South African Field Test CME
GENEVA -- A rapid molecular assay for drug-resistant tuberculosis passed with flying colors when field-tested in a busy South African reference lab, researchers here said. full story
http://www.medpagetoday.com/InfectiousDisease/Tuberculosis/tb/8987

Donor Age Not Factor in Corneal Transplant Success CME (with audio)
CINCINNATI -- Corneas from eyes up to 75 years old may be transplanted without sacrificing long-term success rates, researchers said in a finding that could swell the corneal donor pool by 20% to 35%. full story
http://www.medpagetoday.com/Ophthalmology/GeneralOphthalmology/tb/8977

ACC: ARBs and ACE Inhibitors Equal Separately but Together They Fall CME
CHICAGO -- Individually the angiotensin receptor blocker telmisartan (Micardis) and the ACE inhibitor ramipril (Altace) seem equal for high-risk cardiovascular patients without heart failure, but combined they are bad bedfellows. full story
http://www.medpagetoday.com/MeetingCoverage/ACCMeeting/tb/8984

ACC: Direct Renin Inhibition Reduces Left Ventricular Damage from Hypertension CME
CHICAGO -- The direct renin inhibitor aliskiren (Tekturna) appears as effective as the gold standard for reversing left ventricular hypertrophy with noninferiority to the angiotensin receptor blocker losartan (Cozaar), researchers reported here. full story
http://www.medpagetoday.com/MeetingCoverage/ACCMeeting/tb/8983

Genomic Data Can Give a Better Idea of Breast Cancer Prognosis CME
DURHAM, N.C. -- Patterns of gene expression can help refine prognosis in early breast cancer, researchers here said. full story
http://www.medpagetoday.com/HematologyOncology/BreastCancer/tb/8976

ACC: High-Dose Atorvastatin (Lipitor) Reduces Carotid Lesion Inflammation CME
CHICAGO -- In patients with carotid stenosis, high doses of atorvastatin (Lipitor) reduced inflammation and microemboli, as revealed by a high resolution imaging method. full story
http://www.medpagetoday.com/MeetingCoverage/ACCMeeting/tb/8981

ACC: Pioglitazone (ACTOS) May Slow Atherosclerosis Progression CME (with video)
CHICAGO -- The diabetes drug pioglitazone (ACTOS) led to a significant slowing of atherosclerosis, albeit small, as measured by intravascular ultrasound, compared with glimepiride, researchers said here. full story
http://www.medpagetoday.com/MeetingCoverage/ACCMeeting/tb/8969

ACC: Calcium Channel Blocker Beats Diuretic for Initial BP Combo Therapy CME
CHICAGO -- A calcium channel blocker may be a better choice than the standard diuretic for initial combination therapy to treat high blood pressure, researchers found. full story
http://www.medpagetoday.com/MeetingCoverage/ACCMeeting/tb/8979

Tai Chi May Help Improve Markers of Pre-Diabetes CME
BRISBANE, Australia -- For patients at risk of metabolic syndrome and type 2 diabetes, the Chinese exercises Tai Chi and Qigong may improve clinical parameters associated with the conditions, two small studies suggested. full story
http://www.medpagetoday.com/Endocrinology/Diabetes/tb/8973


CME SPOTLIGHT
Managing CardioMetabolic Complexities
You are invited to participate in the following free educational activity where you will learn about the interrelated factors contributing to the metabolic syndrome and novel therapeutic strategies aimed at attenuating cardiometabolic risk while delaying disease progression.
Source:
SciMed New York
[more]

The Quest for Erythropoiesis: A Preoperative Red Blood Cell Production
This Web activity, featuring experts in the field of blood management, provides a data-driven approach to the preoperative management of anemia in patients undergoing elective surgery.
Source:
AdvancMed
[more]

Community-Acquired Pneumonia: Translating Clinical Practice and Management Into Quality Outcomes
Join Dr. Amin for an innovative and in-depth CME-certified Activity on community acquired pneumonia and translating clinical practice and management into quality outcomes.
Source:
CME Enterprise
[more]

Hepatitis C: From Scientific Foundations to New Vistas in Treatment
This webcast explores what is known about the HCV life cycle, host immune response to HCV, and nonresponse to treatment, and provides updates on the latest STAT-C agents and other novel HCV treatments.
Source:
Projects In Knowledge
[more]

Heart Failure: From Emergency Department to Discharge
Join Drs. Frank Michota and Charles Emerman, as they provide the evidence-based science to support physicians in making critical decisions about appropriate ADHF management. This interactive CME activity will review effective diagnosis and treatment strategies in the ED, during admission, and after discharge to prevent rehospitalizations and improve patient healthcare outcomes.
Source:
Med-IQ
[more]

A Customized Approach to the Management of Hepatitis B Viral Infection
This CME journal supplement is case-based and provides practical approaches to halting the natural history of HBV infection, to tailoring HBV therapy, and to treating pregnant or immunosuppressed patients infected with HBV.
Source:
AdvancMed
[more]

Adequate Relief: Optimal Opioid Dosing and Side-Effect Management for Long-Term Care Patients
This CME/CE certified monograph addresses optimal opioid dosing and side effect management for long-term care patients.
Source:
Interstate Postgraduate Medical Association and MEV Healthcom, Inc.
[more]

Emerging Trends in the Treatment of Renal Cell Carcinoma
Drs. Michael B. Atkins, Bernard J. Escudier, and Gary R. Hudes lead this CME activity which examines current and evolving standards of care for the treatment of early stage and advanced renal cell carcinoma; best practices for optimal patient outcomes are also covered.
Source:
The Physicians Academy For Clinical and Management Excellence
[more]

Medical and Surgical Management of Aortic Valve Disease
Join Dr. Joseph E. Bavaria, MD and the team of University of Pennsylvania cardiology and surgery specialists in reviewing of all the important topics related to aortic valve conditions that a cardiovascular clinician faces on a daily basis.
Source:
University of Pennsylvania School of Medicine
[more]


JOURNAL DOWNLOADS
First-line SUTENT® data recently published in NEJM
Read first-line SUTENT data in the New England Journal of Medicine. Get it at SUTENThcp.com Source: Pfizer [more]


RESOURCES
Why not provide greater LDL-C efficacy for your appropriate newly initiated patients?
View the data on 50% mean reduction right from the start. Source: Merck [more]

Now Approved: A new development in the treatment of hypertension.
Now approved from Forest Laboratories: Bystolic (nebivolol). A novel beta blocker for the treatment of hypertension. Click here to learn more. Source: Forest Labs [more]

Access information on more than 150 Pfizer products at PfizerPro.com
Pfizer medicines have a new home on the Web. Visit PfizerPro.com for information on more than 150 Pfizer products. Convenient access to full prescribing information, scientific literature, professional resources, patient education material, and more. Source: Pfizer [more]

Take a closer look at all 3 major lipids and cardiovascular risk. HDL, LDL and TG levels may be independently associated with cardiovascular risk.
Visit www.totallipds.com, a new source of information for health care professionals, about dyslipidemia, all 3 lipids, and cardiovascular risk. Source: Merck [more]

Explore the Possibilities in Type 2 Diabetes.
Type 2 diabetes studies: Understand mechanism of action for a different treatment option. Learn more today. Source: Merck [more]


Featured Job Opportunities from MedJobs Today
  • Urology, Arkansas
    Position consists of clinic, hospital consults, and surgery, and there is ER coverage with a minimum of 10 days per month.
    http://www.medjobstoday.com/seeker/job_detail.cfm?jobid=17311&refsrc=dh
  • Urology, New York
    A teaching facility in upstate New York is seeking two urologists to place for clinic and call coverage.
    http://www.medjobstoday.com/seeker/job_detail.cfm?jobid=17590&refsrc=dh
  • Urology, Wisconsin
    This opening is for weekend call coverage from Friday evening at 5pm to Monday morning at 8am.
    http://www.medjobstoday.com/seeker/job_detail.cfm?jobid=17779&refsrc=dh
Visit MedJobs Today.com to search for a new job!


Best of MedpageToday
 

CROI Meeting
CROI: Atazanavir Equals Lopinavir in Head-On Contest
CROI: Extended HIV Treatment for Babies Reduces Breast-Milk Risk

SABCS Meeting
SABCS: Optimizing Breast Cancer Treatment with Biologics
SABCS: A Call to Scrap Anthracyclines for Breast Cancer

ACG Meeting
ACG: Weight Gain with Infliximab in Crohn's Disease Confirmed but Not Explained
ACG: Natalizumab Demonstrates Activity in Crohn's Disease After
Anti-TNF Failure


AHA Meeting
AHA: Step Care Hypertension Algorithm Gets Patients to Goals
AHA: Women Have More Complications than Men with ICD Implants


News + CME: MedPageToday on your PDA
News + CME: MedPageToday on your PDA
At MedPage Today™, we’re PUTTING BREAKING MEDICAL NEWS INTO PRACTICE™.

You have received this email because you have registered to receive alert emails at www.medpagetoday.com, with the email address: delphine1939@videotron.ca. You can easily manage your subscriptions by clicking on the "Edit Profile" link below.

SUBSCRIBE OR UNSUBSCRIBE:
Edit Profile

TECHNICAL QUESTIONS:
webmaster@medpagetoday.com

MedPage Today, LLC.
Overlook at Great Notch
150 Clove Road
Little Falls, New Jersey 07424
Telephone: (973) 890-0985
Fax: (973) 890-1327


Go BackHomeGo Forward